Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Okay Hostile Take Over
View:
Post by SundayMovies on Dec 08, 2022 10:20am

Okay Hostile Take Over

I hope the market push the market cap to 350-400 millions range so that we can refinanced.
Otherwise, we will have to accept a lowball partnership offer for either pancreatic or breast cancer...

On the flip side, this company is so so so vulnerabel now for a hostile take over.
You got now 3 different trials indicating potential cure for cancer...

Skin cancer 3years+ survival (market has forgotten this one)
Goblet 1 - Patient 013 got a complet response
Adlai (dosage escalation trial) Yup in a boring dosage escation we got 1 PR and still alive after one year...

Time to unload your crypto zeros and buy this company up. Otherwise, we get an hostile low ball take over in the coming weeks...

Anyway, because the shareholders are so depressed beyond hope. A hostile take over would work here.

I be sad (hostile take over) but still very happy to with my return on investment... So, please do it (AstraZeneca). I would tender my shares.
Comment by tileb81 on Dec 08, 2022 12:51pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities